Venous Thromboembolism Treatment Market To Reach USD 2.13 Bn By 2032 8.50% CAGR (2024-2032)
Venous Thromboembolism Treatment Market The venous Thromboembolism Treatment Market growth is driven by rising VTE prevalence, anticoagulan ...
Medscape26d
Risk of Venous Thromboembolism Among Hospitalized Medically Ill Patients
Using a large U.S. health care claims database, we found that 1.58% of hospitalized medically ill patients-or about one in every 63 such admissions-develop clinical VTE over 90 days. The ...